0
Advanced Search
Journal Articles about Antipsychotics Showing 61-80 of 1319
Psychiatric Services >
Article | February 01, 2010
Off-Label Use of Second-Generation Antipsychotic Agents Among Elderly Nursing Home Residents
Pravin Kamble, B.Pharm., M.S.; Jeff Sherer, Pharm.D., M.P.H.; Hua Chen, M.D., Ph.D.; Rajender Aparasu, M.Pharm., Ph.D.
Psychiatric Services. 2010 February ; 2(61):130-136
PDFPDF
Psychiatric Services >
Taking Issue | February 01, 2010
Weighing Scientific Evidence: Let's Keep the Blindfold Off
Bonnie T. Zima, M.D., M.P.H.
Psychiatric Services. 2010 February ; 2(61):107-107
PDFPDF
Psychiatric Services >
Column | January 01, 2010
Datapoints: Depot Antipsychotic Use in New York State Hospitals, 1994 to 2009
Leslie Citrome, M.D., M.P.H.; Ari Jaffe, M.D.; Jerome Levine, M.D.
Psychiatric Services. 2010 January ; 1(61):9-9
PDFPDF
The American Journal of Psychiatry >
Article | December 15, 2009
Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia
John M. Kane, M.D.; Holland C. Detke, Ph.D.; Dieter Naber, M.D.; Gopalan Sethuraman, Ph.D.; Daniel Y. Lin, Ph.D.; Richard F. Bergstrom, Ph.D.; David McDonnell, M.B., M.R.C.Psych.
The American Journal of Psychiatry. 2009 December ; 2(167):181-189
PDFPDF  |    Supplemental Content
Psychiatric Services >
Article | December 01, 2009
Commentary: Real-Time Computerized Support Systems
John M. Davis, M.D.; Daniel J. Luchins, M.D.
Psychiatric Services. 2009 December ; 12(60):1603-1603
PDFPDF
Psychiatric Services >
Brief Report | December 01, 2009
Metabolic Risk Factors Among Medicaid Outpatients With Schizophrenia Receiving Second-Generation Antipsychotics
Ryan C. Bell, J.D., M.D.; Sharon Farmer, M.D.; Richard Ries, M.D.; Debra Srebnik, Ph.D.
Psychiatric Services. 2009 December ; 12(60):1686-1689
PDFPDF  |    Supplemental Content
The American Journal of Psychiatry >
Reviews and Overviews | November 16, 2009
Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action
Zachary Freyberg, M.D., Ph.D.; Stephen J. Ferrando, M.D.; Jonathan A. Javitch, M.D., Ph.D.
The American Journal of Psychiatry. 2009 November ; 4(167):388-396
PDFPDF  |  CME Activity (1)
The American Journal of Psychiatry >
Reviews and Overviews | November 01, 2009
Clinical Trials Design Lessons From the CATIE Study
Helena Chmura Kraemer, Ph.D.; Ira D. Glick, M.D.; Donald F. Klein, M.D.
The American Journal of Psychiatry. 2009 November ; 11(166):1222-1228
PDFPDF
Psychiatric Services >
Column | October 01, 2009
Case Studies in Public-Sector Leadership: Implementing a Metabolic Initiative in a Community Mental Health Clinic
Dianna Dragatsi, M.D.; Susan M. Deakins, M.D.
Psychiatric Services. 2009 October ; 10(60):1298-1301
PDFPDF
The American Journal of Psychiatry >
Reviews and Overviews | September 01, 2009
Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
J. Craig Nelson, M.D.; George I. Papakostas, M.D.
The American Journal of Psychiatry. 2009 September ; 9(166):980-991
PDFPDF
Psychiatric Services >
Article | September 01, 2009
Off-Label Use of Antipsychotic Medications in the Department of Veterans Affairs Health Care System
Douglas L. Leslie, Ph.D.; Somaia Mohamed, M.D., Ph.D.; Robert A. Rosenheck, M.D.
Psychiatric Services. 2009 September ; 9(60):1175-1181
PDFPDF
The American Journal of Psychiatry >
Article | June 01, 2009
Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)
Michael Davidson, M.D.; Silvana Galderisi, M.D.; Mark Weiser, M.D.; Nomi Werbeloff, Ph.D.; Wolfgang W. Fleischhacker, M.D.; Richard S. Keefe, Ph.D.; Han Boter, Ph.D.; Ireneus P.M. Keet, M.D., Ph.D.; Dan Prelipceanu, M.D.; Janusz K. Rybakowski, M.D.; Jan Libiger, M.D.; Martina Hummer, M.D.; Sonia Dollfus, M.D.; Juan J. López-Ibor, M.D.; Luchezar G. Hranov, M.D., Ph.D.; Wolfgang Gaebel, M.D.; Joseph Peuskens, M.D.; Nils Lindefors, M.D.; Anita Riecher-Rössler, M.D.; René S. Kahn, M.D.
The American Journal of Psychiatry. 2009 June ; 6(166):675-682
PDFPDF  |    Supplemental Content
The American Journal of Psychiatry >
Article | June 01, 2009
Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia
Carla M. Canuso, M.D.; Bryan Dirks, M.D.; Jennifer Carothers, Sc.D., M.B.A.; Colette Kosik-Gonzalez, M.A.; Cynthia A. Bossie, Ph.D.; Young Zhu, Ph.D.; C. V. Damaraju, Ph.D.; Amir H. Kalali, M.D.; Ramy Mahmoud, M.D., M.P.H.
The American Journal of Psychiatry. 2009 June ; 6(166):691-701
PDFPDF
FOCUS >
CLINICAL SYNTHESIS | June 01, 2009
Psychiatric Involvement in Obesity Treatment
Alicia R. Ruelaz, M.D.
FOCUS. 2009 June ; 3(7):311-316
PDFPDF  |  CME Activity (2)
FOCUS >
CLINICAL SYNTHESIS | June 01, 2009
Ask the Expert: Psychosomatic Medicine/Delirium
José R. Maldonado, M.D.
FOCUS. 2009 June ; 3(7):336-342
PDFPDF
FOCUS >
CLINICAL SYNTHESIS | June 01, 2009
Quick Reference Psychosomatic Medicine: Med-Psych Drug-Drug Interactions Update An Overview of Psychotropic Drug-Drug Interactions
FOCUS. 2009 June ; 3(7):347-364
PDFPDF
The American Journal of Psychiatry >
Article | May 01, 2009
Metabolic Changes Associated With Second-Generation Antipsychotic Use in Alzheimer’s Disease Patients: The CATIE-AD Study
Ling Zheng, M.B.B.S., Ph.D.; Wendy J. Mack, Ph.D.; Karen S. Dagerman, M.S.; John K. Hsiao, M.D.; Barry D. Lebowitz, Ph.D.; Constantine G. Lyketsos, M.D., M.H.S.; T. Scott Stroup, M.D.; David L. Sultzer, M.D.; Pierre N. Tariot, M.D.; Cheryl Vigen, Ph.D.; Lon S. Schneider, M.D.
The American Journal of Psychiatry. 2009 May ; 5(166):583-590
PDFPDF
The American Journal of Psychiatry >
Article | April 01, 2009
Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127)
Trisha Suppes, M.D., Ph.D.; Eduard Vieta, M.D., Ph.D.; Sherry Liu, Ph.D.; Martin Brecher, M.D.; Björn Paulsson, M.D.; Trial 127 Investigators
The American Journal of Psychiatry. 2009 April ; 4(166):476-488
PDFPDF  |    Supplemental Content
Psychiatric Services >
Brief Report | April 01, 2009
Psychiatric Illness and Obesity: Recognizing the "Obesogenic" Nature of an Inpatient Psychiatric Setting
Guy E. J. Faulkner, M.Sc., Ph.D.; Paul F. Gorczynski, B.H.Sc., M.A.; Tony A. Cohn, M.B.Ch.B., M.Sc.
Psychiatric Services. 2009 April ; 4(60):538-541
PDFPDF
The American Journal of Psychiatry >
Article | March 01, 2009
Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents
Dan W. Haupt, M.D.; Lisa C. Rosenblatt, M.D.; Edward Kim, M.D., M.B.A.; Ross A. Baker, Ph.D., M.B.A.; Richard Whitehead, B.S.; John W. Newcomer, M.D.
The American Journal of Psychiatry. 2009 March ; 3(166):345-353
PDFPDF
Copyright ©
American
Psychiatric
Association